Amgen partners with Flagship’s machine learning startup, promising up to $1.9B as Big Pharma ups bet on AI

Amgen is approaching the new year the same way it tackled 2021: swinging deals. But now it’s aiming to bring AI capabilities into the fold.

The big biopharma is partnering with Flagship’s Generate Biosciences on five therapeutic programs, the companies announced Thursday morning, in a collaboration that seeks to pair...

Click to view original post